Anemia, Hemolytic: Clinical Trials

1,899 trials for Anemia, Hemolytic, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

997 completed, 247 recruiting, 194 unknown, 171 terminated. 506 Phase 2, 369 Not applicable, 280 Phase 1, 231 Phase 3, 87 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 2506Completed 257, Terminated 65, Recruiting 61, Unknown 42, Active not recruiting 38, Withdrawn 26, Not yet recruiting 16, Enrolling by invitation 1
Not applicable369Completed 207, Recruiting 52, Unknown 41, Terminated 23, Not yet recruiting 21, Active not recruiting 15, Withdrawn 6, Suspended 3, Enrolling by invitation 1
Phase 1280Completed 143, Recruiting 39, Terminated 33, Active not recruiting 25, Not yet recruiting 13, Unknown 13, Withdrawn 13, Enrolling by invitation 1
Phase 3231Completed 117, Terminated 37, Recruiting 27, Unknown 19, Active not recruiting 13, Not yet recruiting 12, Withdrawn 5, Enrolling by invitation 1
Phase 487Completed 47, Unknown 13, Recruiting 7, Terminated 7, Withdrawn 6, Active not recruiting 3, Not yet recruiting 3, Enrolling by invitation 1
Early Phase 131Completed 9, Recruiting 8, Not yet recruiting 4, Unknown 4, Terminated 2, Withdrawn 2, Active not recruiting 1, Enrolling by invitation 1

Follow Anemia, Hemolytic: new trials by email Literature Review of Anemia, Hemolytic trials Research Report on Anemia, Hemolytic

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease
KL003 Cell Injection - Sickle Cell Disease
Not applicableSuspendedInstitute of Hematology & Blood Diseases Hospital, China32028-03-012026-11-05
Study of NM8074 in Patients With aHUS With Evidence of Ongoing Thrombotic Microangiopathy
NM8074 - aHUS - Atypical Hemolytic Uremic Syndrome
Phase 2Not yet recruitingNovelMed Therapeutics122027-11-012026-04-13
Self-administered Acupressure in Patients With Sickle Cell Disease
Verum Acupressure (using AcuWand), Sham Acupressure (using AcuWand) - Sickle Cell Disease (SCD)
Not applicableNot yet recruitingUniversity of Cincinnati3002027-10-012026-10-15
Development of a Provider-Focused Intervention to Improve Health Outcomes in Pediatric Sickle Cell Disease
Individuation and Perspective-Taking (IPT), pediatric SCD pain management education session - Sickle Cell Disease, Sickle Cell Anemia in Children
Not applicableNot yet recruitingConnecticut Children's Medical Center302027-09-012026-04-29
Evaluation of Efficacy and Safety of a Single Dose of Exa-cel in Participants With Severe Sickle Cell Disease, βS/ βC Genotype
Exa-cel - Sickle Cell Disease
Phase 3WithdrawnVertex Pharmaceuticals Incorporated2027-07-312026-03-25
Data Collection For Patients With Sickle Cell Disease
data collection - Data Collection, Sickle Cell Disease
Not yet recruitingM.D. Anderson Cancer Center5002027-04-062026-11-03
MBI for Pain and Sleep in Adolescents and Young Adults With Sickle Cell Disease
Mindfulness-based intervention - Chronic Pain, Sickle Cell Disease
Not applicableNot yet recruitingUniversity of Illinois at Chicago482027-02-012026-09-21
A Study of Efficacy and Safety of FXS6837 in Anti-C5 Treated PNH Patients.
FXS6837 Capsule - Paroxysmal Nocturnal Hemoglobinuria
Phase 3Not yet recruitingShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.202027-01-262026-11-04
Focused Ultrasound Neuromodulation for Chronic Pain
Focused PCM-Guided CMN LIFU, Unfocused Control LIFU - Chronic Pain, Sickle Cell Disease
Not applicableNot yet recruitingUniversity of Minnesota802027-01-042026-11-02
Mechanisms Within the Autonomic Nervous SysTEm undeRlying MusIc Therapy's aNalgesic Effects in Sickle Cell Disease (MASTERMIND)
Music Therapy - Sickle Cell Disease
Not applicableNot yet recruitingUniversity Hospitals Cleveland Medical Center102027-01-022026-11-10
Study of NM8074 in Adult PNH Patients With Inadequate Response to Soliris
NM8074, Soliris - Paroxysmal Nocturnal Hemoglobinuria
Phase 2Not yet recruitingNovelMed Therapeutics122027-01-012026-04-13
Buprenorphine for the Management of Pain in Children With Sickle Cell Disease
Buprenorphine Buccal Film [Belbuca] - Sickle Cell Disease (SCD), Sickle Cell Disease Vaso-occlusive Crisis
Phase 1Not yet recruitingNatasha Archer252027-01-012026-11-04
Heterologous Cord Blood-Derived Red Blood Cell for Transfusion in Extremely Preterm Infants
Cord Blood Red Blood Cells, Standard Adult Donor Red Blood Cells - Extremely Premature Infant, Anemia Neonatal
Not applicableNot yet recruitingHospital Clinic of Barcelona2802027-01-012026-11-09
Gene Therapy of Beta Thalassemia Using a Self-inactivating Lentiviral Vector
Gene-modified autologous hematopoeitic stem cells - Beta-Thalassemia
Not applicableNot yet recruitingShenzhen Geno-Immune Medical Institute202026-12-312026-11-02
IASO206 in Patients With Relapsed/Refractory Autoimmune Hemolytic Anemia
IASO206 injection - Autoimmune Hemolytic Anemia, Relapsed/Refractory
Phase 1Not yet recruitingInstitute of Hematology & Blood Diseases Hospital, China182026-12-152026-11-05
Effect of Nursing Intervention on Treatment Burden and Self-management Among Adolescents With Thalassemia
Orem's Self-Care Nursing Program - Thalassemia Majors (Beta-Thalassemia Major)
Not applicableNot yet recruitingUniversity of Baghdad1502026-12-132026-11-20
A Study of the Efficacy and Safety of FXS6837 Capsules Compared to Eculizumab for 24 Weeks in Patients With PNH.
FXS6837 Capsule, Eculizumab infusion - Paroxysmal Nocturnal Hemoglobinuria
Phase 3Not yet recruitingShanghai Fosun Pharmaceutical Industrial Development Co. Ltd.902026-12-102026-08-05
A Phase 1b/2a Study of Velinotamig in Adults With Relapsed/Refractory ITP and wAIHA
Velinotamig specified dose on specified days. - Immune Thrombocytopenia (ITP), Warm Autoimmune Hemolytic Anemia (WAIHA)
Phase 1 / Phase 2Not yet recruitingCullinan Therapeutics Inc.722026-12-012026-07-31
Omega-3-Fatty Acids in Children With Sickle Cell Disease
Flaxseed - Sickle Cell Disease (SCD)
Not applicableNot yet recruitingUniversity of Alabama at Birmingham202026-12-012026-08-21
Minocycline In Neurocognitive Outcomes - Sickle Cell Disease
Minocycline, Placebo - Sickle Cell Disease, Cognitive Impairment
Phase 1Not yet recruitingUniversity of Cincinnati302026-12-012026-11-03

Showing 20 of 1899. Sign in to see all of them.

Narrower conditions

Anemia, Sickle Cell (1124)  ·  beta-Thalassemia (265)  ·  Thalassemia (222)  ·  Hemoglobinuria, Paroxysmal (190)  ·  Vaso-Occlusive Crises (103)  ·  Hematologic Diseases (84)  ·  Anemia, Hemolytic, Autoimmune (83)  ·  Anemia (80)  ·  Hemoglobinopathies (70)  ·  Iron Overload (65)  ·  Pain (58)  ·  Myelodysplastic Syndromes (46)  ·  Atypical Hemolytic Uremic Syndrome (45)  ·  Hemolysis (43)

Broader conditions

Hemic and Lymphatic Diseases (1898)  ·  Anemia (1819)  ·  Hematologic Diseases (1815)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1556)  ·  Anemia, Hemolytic, Congenital (1531)  ·  Genetic Diseases, Inborn (1519)  ·  Hemoglobinopathies (1419)  ·  Pathological Conditions, Signs and Symptoms (330)  ·  Bone Marrow Diseases (256)  ·  Thalassemia (229)  ·  Pathologic Processes (211)  ·  Nutritional and Metabolic Diseases (192)  ·  Immune System Diseases (190)  ·  Metabolic Diseases (178)

Interventions

Hydroxyurea (88)  ·  eculizumab (49)  ·  Cyclophosphamide (43)  ·  Alemtuzumab (40)  ·  Deferasirox (39)  ·  fludarabine (37)  ·  fludarabine phosphate (34)  ·  Sirolimus (32)  ·  Blood Specimen Collection (31)  ·  Busulfan (28)  ·  Whole-Body Irradiation (28)  ·  Mycophenolic Acid (26)  ·  Deferoxamine (23)  ·  voxelotor (23)  ·  Tacrolimus (22)

Sponsors

National Heart, Lung, and Blood Institute (NHLBI) (71)  ·  Novartis Pharmaceuticals (63)  ·  Assistance Publique - Hôpitaux de Paris (54)  ·  St. Jude Children's Research Hospital (50)  ·  Alexion Pharmaceuticals, Inc. (48)  ·  Children's Hospital Medical Center, Cincinnati (33)  ·  Assiut University (31)  ·  Duke University (28)  ·  Emory University (28)  ·  Pfizer (27)  ·  Institute of Hematology & Blood Diseases Hospital, China (24)  ·  HaEmek Medical Center, Israel (19)  ·  UCSF Benioff Children's Hospital Oakland (17)  ·  Ain Shams University (16)  ·  University of Illinois at Chicago (14)

Countries

United States (954)  ·  France (214)  ·  United Kingdom (171)  ·  Italy (164)  ·  China (158)  ·  Canada (122)  ·  Germany (89)  ·  Egypt (81)  ·  Turkey (Türkiye) (77)  ·  Spain (72)  ·  Netherlands (70)  ·  Belgium (58)  ·  Brazil (58)  ·  Lebanon (58)  ·  Greece (53)

Top investigators

John F Tisdale, M.D. (16)  ·  Ariel Koren, MD (12)  ·  Swee Lay Thein, M.D. (12)  ·  Lakshmanan Krishnamurti, MD (9)  ·  Janet Kwiatkowski, MD (7)  ·  Russell Ware, MD, PhD (7)  ·  Carina Levin, MD (6)

Results publications

PMID 37975597, PMID 33783815, PMID 36240296, PMID 37254256, PMID 38775255, PMID 40277027, PMID 40569673, PMID 41026975, PMID 42133908, PMID 23738544, PMID 26589907, PMID 34175041, PMID 34219224, PMID 20175775, PMID 24916507, PMID 31974203, PMID 33661274, PMID 34922648, PMID 36594181, PMID 36860093, PMID 36975201, PMID 38866240, PMID 39079163, PMID 39382077, PMID 39428602, PMID 39535306, PMID 39659429, PMID 40694294, PMID 41809202, PMID 42705233, PMID 17634466, PMID 19721013, PMID 23416852, PMID 29931453, PMID 30617198, PMID 30655275, PMID 30952488, PMID 31799940, PMID 32384147, PMID 33283989, PMID 33570654, PMID 34000072, PMID 34526067, PMID 35019238, PMID 35075288, PMID 35120836, PMID 35869170, PMID 35981565, PMID 36123234, PMID 36355805

NIH funding

2019 (19), 2023 (17), 2017 (14), 2014 (12), 2016 (11), 2018 (8), U01HL065238 (8), U54HL070587 (8), 2015 (4), U01HL133996 (4), 2009 (3), 2025 (3), P30CA033572 (3), 2004 (2), K23HL094376 (2)